T A Longacre

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Serous tumours of low malignant potential (serous borderline tumours): moving toward détente
    T A Longacre
    Department of Pathology, Stanford University, Stanford, CA, USA
    Histopathology 47:315-8. 2005
  2. ncbi request reprint Recommendations for the reporting of fallopian tube neoplasms
    Teri A Longacre
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Hum Pathol 38:1160-3. 2007
  3. doi request reprint Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type
    Justin Cuff
    Department of Surgical Pathology, Stanford University School of Medicine, CA 94305, USA
    Am J Surg Pathol 36:688-95. 2012
  4. ncbi request reprint Recommendations for the reporting of fallopian tube neoplasms
    Teri A Longacre
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Virchows Arch 450:25-9. 2007
  5. doi request reprint Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications
    William M Rogers
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Am J Surg Pathol 32:799-809. 2008
  6. ncbi request reprint Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up
    Teri A Longacre
    Department of Pathology, Stanford University, 300 Pasateur Drive, Stanford, CA 94305, USA
    Am J Surg Pathol 29:707-23. 2005
  7. doi request reprint Diagnostic problems in anal pathology
    Teri A Longacre
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Adv Anat Pathol 15:263-78. 2008
  8. ncbi request reprint Chemo-radiotherapy for localized pancreatic cancer: increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil
    J C Poen
    Department of Radiation Oncology, Stanford University, CA 94305, USA
    Int J Radiat Oncol Biol Phys 40:93-9. 1998
  9. pmc CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer
    Jeffrey A Norton
    Department of Surgery, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94035, USA
    Ann Surg 245:873-9. 2007
  10. ncbi request reprint Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum
    Christina S Kong
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    Am J Surg Pathol 31:919-25. 2007

Collaborators

Detail Information

Publications48

  1. ncbi request reprint Serous tumours of low malignant potential (serous borderline tumours): moving toward détente
    T A Longacre
    Department of Pathology, Stanford University, Stanford, CA, USA
    Histopathology 47:315-8. 2005
  2. ncbi request reprint Recommendations for the reporting of fallopian tube neoplasms
    Teri A Longacre
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Hum Pathol 38:1160-3. 2007
    ....
  3. doi request reprint Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type
    Justin Cuff
    Department of Surgical Pathology, Stanford University School of Medicine, CA 94305, USA
    Am J Surg Pathol 36:688-95. 2012
    ..Until more data are collected, pathologists should classify ovarian tumors with mixed histology as a separate and potentially unique biological and prognostic group...
  4. ncbi request reprint Recommendations for the reporting of fallopian tube neoplasms
    Teri A Longacre
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Virchows Arch 450:25-9. 2007
  5. doi request reprint Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications
    William M Rogers
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Am J Surg Pathol 32:799-809. 2008
    ..The observed site predilection suggests a possible role for geographically targeted endoscopic surveillance biopsy in patients who elect to delay surgical intervention...
  6. ncbi request reprint Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up
    Teri A Longacre
    Department of Pathology, Stanford University, 300 Pasateur Drive, Stanford, CA 94305, USA
    Am J Surg Pathol 29:707-23. 2005
    ..The small, but significant risk of progression over time to low-grade serous carcinoma emphasizes the need for prolonged follow-up in patients with S-LMP...
  7. doi request reprint Diagnostic problems in anal pathology
    Teri A Longacre
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Adv Anat Pathol 15:263-78. 2008
    ..As all anal condylomata may harbor foci of high-grade dysplasia or invasive carcinoma, careful sectioning and complete histologic examination is required...
  8. ncbi request reprint Chemo-radiotherapy for localized pancreatic cancer: increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil
    J C Poen
    Department of Radiation Oncology, Stanford University, CA 94305, USA
    Int J Radiat Oncol Biol Phys 40:93-9. 1998
    ..This study compares treatment intensity and acute toxicity of consecutive protocols of concurrent RT and 5-FU by bolus injection or PVI...
  9. pmc CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer
    Jeffrey A Norton
    Department of Surgery, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94035, USA
    Ann Surg 245:873-9. 2007
    ....
  10. ncbi request reprint Role of human papillomavirus in squamous cell metaplasia-dysplasia-carcinoma of the rectum
    Christina S Kong
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    Am J Surg Pathol 31:919-25. 2007
    ..Further studies are warranted to determine if SCC occurring more proximal in the colon are also HPV-dependent or occur via another, HPV-independent pathway...
  11. doi request reprint Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential
    Ankur R Sangoi
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Am J Surg Pathol 32:269-74. 2008
    ..As CCC and S-LMP exhibit significantly different immunoreactivity for Wilms' Tumor 1 and estrogen receptor, these markers may also be useful adjunctive tests in problematic cases...
  12. ncbi request reprint p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia
    Christina S Kong
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    Am J Surg Pathol 31:33-43. 2007
    ....
  13. doi request reprint Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary
    Ghada E Esheba
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Am J Surg Pathol 32:600-7. 2008
    ..0001). Because GPC3 may be associated with alpha-fetoprotein expression, further studies are required to determine the utility of GPC3 in differentiating YST from CCC with hepatoid differentiation...
  14. ncbi request reprint Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms: a tissue microarray study of 1,754 cases
    Neeraja Kambham
    Department of Pathology, Stanford University School of Medicine, CA 94305, USA
    Appl Immunohistochem Mol Morphol 13:304-10. 2005
    ..Furthermore, the two commercially available monoclonal CD138 antibodies tested in this study showed significant differences in their immunoreactivity in different tumor types...
  15. ncbi request reprint CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma
    Atsuko Shibata
    Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA 94305, USA
    Carcinogenesis 23:419-24. 2002
    ..The data suggest that CagA(+) H. pylori infection, when compared with CagA(-) infection or the absence of H. pylori infection, is associated with a higher prevalence of p53 mutation in gastric adenocarcinoma...
  16. doi request reprint Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence
    Reetesh K Pai
    Department of Pathology, Stanford University, Stanford, CA, USA
    Am J Surg Pathol 33:1425-39. 2009
    ..Appendiceal mucinous neoplasms can be stratified into 4 distinct risk groups on the basis of a careful histopathologic assessment of cytoarchitectural features and extent of disease at presentation...
  17. pmc Gene expression patterns in ovarian carcinomas
    Marci E Schaner
    Stanford University School of Medicine, Stanford, California 94305 5151, USA
    Mol Biol Cell 14:4376-86. 2003
    ....
  18. doi request reprint A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas
    Christina S Kong
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305 5324, USA
    Am J Surg Pathol 34:915-26. 2010
    ..However, these panels do not perform well with special variant carcinomas...
  19. doi request reprint Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger
    Kristin C Jensen
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Am J Surg Pathol 32:1029-37. 2008
    ..The occurrence of MMR inactivation in a significant proportion of ovarian clear cell carcinomas (17% in this study) suggests that this tumor may warrant targeted testing in women <or=50 years of age...
  20. pmc Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers
    C A Hamilton
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
    Br J Cancer 94:642-6. 2006
    ..Women with UPSC and CC of the uterus have a significantly poorer prognosis compared to those with G3EC. These findings should be considered in the counselling, treating and designing of future trials for these high-risk patients...
  21. ncbi request reprint Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists
    A Shibata
    Department of Health Research and Policy, Stanford University School of Medicine, California 94305 5405, USA
    Cancer Epidemiol Biomarkers Prev 10:75-8. 2001
    ....
  22. ncbi request reprint Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion
    Jesse K McKenney
    Department of Pathology, Stanford University School of Medicine, CA 94305, USA
    Am J Surg Pathol 30:1209-21. 2006
    ....
  23. doi request reprint Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics
    Jesse K McKenney
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Adv Anat Pathol 16:1-22. 2009
    ..In addition, unusual morphologic patterns of low-grade endometrioid adenocarcinoma should be recognized, as they may cause confusion with other, higher grade (and therefore, more clinically aggressive) endometrial processes...
  24. doi request reprint Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study
    Ankur R Sangoi
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Am J Surg Pathol 32:261-8. 2008
    ..The presence of LVI in microinvasive S-LMP corroborates the view that microinvasion represents an early, but very low risk, invasive process that morphologically links S-LMP and low-grade serous carcinoma...
  25. doi request reprint Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei
    Jesse K McKenney
    Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
    Am J Surg Pathol 32:645-55. 2008
    ..In contrast, teratomas with an invasive carcinomatous component and microscopic peritoneal carcinomatosis follow an aggressive clinical course...
  26. doi request reprint Low-grade mucinous epithelial neoplasm (intestinal type) arising in a mature sacrococcygeal teratoma with late recurrence as pseudomyxoma peritonei
    Jesse K McKenney
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Hum Pathol 39:629-32. 2008
    ..To our knowledge, this is the first reported case of a mature teratoma-associated mucinous epithelial neoplasm from any anatomical site with documented late recurrence as pseudomyxoma peritonei...
  27. doi request reprint Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations
    Ghada E Esheba
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Am J Surg Pathol 33:347-53. 2009
    ..The indeterminate phenotype seen in Walthard nests and ovarian TCC suggests that these proliferations may represent an incomplete or alternate form of differentiation...
  28. doi request reprint Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma
    Ines Gütgemann
    Department of Pathology, Stanford University, Stanford, CA, USA
    Mod Pathol 21:445-54. 2008
    ..These findings represent a potentially important insight into the molecular pathway underlying ovarian carcinogenesis and provide a possible cell cycle model for the development and progression of ovarian clear cell carcinoma...
  29. ncbi request reprint Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification
    Reetesh K Pai
    Department of Pathology, Stanford University School of Medicine, CA 94305, USA
    Adv Anat Pathol 12:291-311. 2005
    ....
  30. ncbi request reprint Outcomes of women with metachronous breast and ovarian carcinomas
    Wen Shiung Liou
    Department of Gynecology and Obstetrics, Stanford Cancer Center, Stanford University School of Medicine, 875 Blake Wilbur Drive, MC 5827, Stanford, CA 94305, USA
    Gynecol Oncol 103:190-4. 2006
    ..We proposed to determine the characteristics and outcomes of women diagnosed with metachronous breast and ovarian cancer...
  31. ncbi request reprint Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives
    Debra A Bell
    Department of Pathology, Massachusetts General Hospital, Boston 02114 2696, USA
    Hum Pathol 35:934-48. 2004
    ....
  32. ncbi request reprint Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification
    Jesse K McKenney
    Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    Am J Surg Pathol 30:614-24. 2006
    ..This high risk pattern of LNI may have a predictive value similar to invasive peritoneal implants and deserves independent evaluation in future studies of S-LMP...
  33. ncbi request reprint Adenomatoid tumors of the female and male genital tracts express WT1
    Erich J Schwartz
    Department of Pathology, Stanford University, Stanford, California 94305, USA
    Int J Gynecol Pathol 23:123-8. 2004
    ....
  34. pmc AXL is an essential factor and therapeutic target for metastatic ovarian cancer
    Erinn B Rankin
    Division of Radiation and Cancer Biology, Department of Radiation Oncology, Center for Clinical Sciences Research, Stanford University, Stanford, California 94305 5152, USA
    Cancer Res 70:7570-9. 2010
    ..Furthermore, this study defines the soluble AXL receptor as a therapeutic candidate agent for treatment of metastatic ovarian cancer, for which current therapies are ineffective...
  35. ncbi request reprint Multinucleated epithelial giant cells in colorectal polyps: a potential mimic of viropathic and/or dysplastic changes
    Neeraja Kambham
    Department of Pathology, Stanford University, Stanford, CA 94305, USA
    Am J Surg Pathol 29:912-9. 2005
    ..These changes appear to represent a nonspecific, possibly degenerative response to inflammation and injury, and should be distinguished from dysplasia...
  36. ncbi request reprint Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion and lymph node metastasis: a histologic pattern mimicking intravascular and sinusoidal histiocytes
    Jesse K McKenney
    Department of Pathology, Stanford University, 300 Pasteur Drive, Stanford, CA 94305, USA
    Int J Gynecol Pathol 24:73-8. 2005
    ..Two cases had regional lymph node metastases composed of morphologically similar cells...
  37. ncbi request reprint Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis
    Margrit M Juretzka
    Division of Gynecologic Oncology, Stanford University School of Medicine, Stanford, CA 94305 5317, USA
    Gynecol Oncol 93:107-11. 2004
    ....
  38. doi request reprint Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression
    Yingbing Wang
    Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305 5494, USA
    Radiology 246:367-75. 2008
    ....
  39. ncbi request reprint Ductal carcinoma in situ of the breast with osteoclast-like giant cells
    Chandra Krishnan
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Hum Pathol 37:369-72. 2006
    ..This case expands the spectrum of tumors associated with OGCs and provides further evidence for the possible role of vascular endothelial growth factor in the stromal-epithelial interactions of in situ mammary carcinoma...
  40. doi request reprint Adenomatoid tumors of the female and male genital tracts: a clinicopathological and immunohistochemical study of 44 cases
    Ankur R Sangoi
    Department of Pathology, Stanford University, Stanford, CA 94039, USA
    Mod Pathol 22:1228-35. 2009
    ..However, the presence of additional, often strong expression of WT-1 in normal tissues of the female genital tract limits the utility of WT-1 in this setting...
  41. ncbi request reprint Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study
    Teri A Longacre
    Department of Pathology, Stanford University, Stanford, CA, USA
    Mod Pathol 19:195-207. 2006
    ....
  42. pmc Transplantation directs oocyte maturation from embryonic stem cells and provides a therapeutic strategy for female infertility
    Cory R Nicholas
    Department of Obstetrics and Gynecology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA 94304, USA
    Hum Mol Genet 18:4376-89. 2009
    ....
  43. ncbi request reprint Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts
    Michelle M M Woo
    Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada
    Gynecol Oncol 93:315-9. 2004
    ..The aim of this study was to examine the expression of oviduct-specific glycoprotein (OGP), a marker of normal oviductal epithelium, for use as a diagnostic or prognostic marker for ovarian cancer...
  44. ncbi request reprint Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management
    Gianpaolo Suriano
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Clin Cancer Res 11:5401-9. 2005
    ..To identify germ line CDH1 mutations in hereditary diffuse gastric cancer (HDGC) families and develop guidelines for management of at risk individuals...
  45. doi request reprint Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases
    Guangming Han
    Department of Pathology and Laboratory Medicine, University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada
    Am J Surg Pathol 32:955-64. 2008
    ..3) Mixed SEC with clear cell and serous components show similar stage, mitotic activities, and immunoreactivities to those of pure SC, and likely represent SC with clear cell changes...
  46. ncbi request reprint Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas
    Lindsay A Brown
    Genetic Pathology Evaluation Centre of the Prostate Centre, University of British Columbia, Room 509, JBRC, 2660 Oak St, Vancouver, BC, Canada V6H 3Z6
    Gynecol Oncol 100:264-70. 2006
    ..Here, we investigate the role of EMSY, a recently described BRCA2 interacting protein, as a key element of the 11q13 amplicon in ovarian cancer. EMSY maps to 11q13.5 and is amplified in 13% of breast and 17% of ovarian carcinomas...
  47. ncbi request reprint Acute colitis secondary to self-administered alcohol enemas: a mimic of ischemic colitis
    Michelle Randolph
    J Clin Gastroenterol 39:78-9. 2005
  48. ncbi request reprint Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling
    C Blake Gilks
    Genetic Pathology Evaluation Centre of the Department of Pathology and Prostate Research Centre, Vancouver General Hospital, British Columbia Cancer Agency and University of British Columbia, Canada
    Gynecol Oncol 96:684-94. 2005
    ..To further examine the molecular differences between these two diseases, we studied the gene expression pattern of ovarian S-LMP and S-Ca using high-density spotted cDNA and tissue microarrays...